GSK lifts annual profit forecast after third quarter beat on vaccines strength Medical Dialogues Bureau31 Oct 2019 9:00 AM ISTGSK now expects full-year profit to be roughly flat compared to last year at constant currency, up from a previous forecast of a fall of 3% to 5%.New...
New GSK shingles vaccine off to strong start in key US market Ruby Khatun Khatun12 April 2018 9:45 AM ISTLONDON: GlaxoSmithKline's (GSK) new shingles vaccine - a priority product as the company strives to improve its drugs line-up - has won more than 90...